An immunotherapy combination could be better than standard “Extreme” chemotherapy as first-line treatment for some…
View More Immunotherapy combination could be alternative to ‘Extreme’ chemotherapy in some head and neck cancersHome »
Combination immunotherapy for advanced bowel cancer approved for NHS in England
People who have previously been treated for a type of bowel cancer that has spread…
View More Combination immunotherapy for advanced bowel cancer approved for NHS in EnglandCombination of drugs boosted survival rates for leukemia patients
Combination of two oral drugs boosted survival rates for leukemia patients from 83% to 96%,…
View More Combination of drugs boosted survival rates for leukemia patientsCombination therapy might improve outcomes in treatment-resistant liver cancer
A combination cancer therapy that is effective against treatment-resistant hepatocellular carcinoma (HCC) by inhibiting tumor…
View More Combination therapy might improve outcomes in treatment-resistant liver cancerRare angiosarcoma tumors respond well to immunotherapy combination
Researchers from SWOG Cancer Research Network, a cancer clinical trials group funded by the National…
View More Rare angiosarcoma tumors respond well to immunotherapy combinationNeo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
In the scientific journal Nature Medicine, researchers in the Netherlands report that neoadjuvant immunotherapy using…
View More Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancerNew study shows long-term durability of early combination therapy in patients newly diagnosed with type 2 diabetes
A new study, VERIFY (Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type…
View More New study shows long-term durability of early combination therapy in patients newly diagnosed with type 2 diabetesPersonalizing precision medicine with combination therapies improves outcomes in cancer
Precision oncology often relies on treating patients with a single, molecularly matched therapy that targets…
View More Personalizing precision medicine with combination therapies improves outcomes in cancer